| Net Cash Provided by (Used in) Operating Activities |
$23,214 |
USD |
-24% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$20,180 |
USD |
-12% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
|
Q1 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
7,737,000 |
shares |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q1 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$2,987 |
USD |
-171% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$3,350 |
USD |
-89% |
Q3 2025 |
Q1 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$20,271 |
USD |
-0.14% |
Q3 2025 |
Q1 2026 |
| Additional Paid in Capital |
$49,410 |
USD |
|
Q3 2025 |
Q1 2026 |
| Interest Expense |
$543 |
USD |
|
Q3 2025 |
Q1 2026 |